Financial results for the year ended March 31, 2024

from the beginning

Financial results for the year ended March 31, 2024

1. Financial results for the year ended March 31, 2024

• The year ended March 31, 2024: Summary

• The year ended March 31, 2024: Financial Highlights

• The year ended March 31, 2024: Performance by Segment

• The year ended March 31, 2024: Imaging Products Business

• The year ended March 31, 2024: Precision Equipment Business

• The year ended March 31, 2024: Healthcare Business

• The year ended March 31, 2024: Components Business

• The year ended March 31, 2024: Digital Manufacturing Business

2. Forecast for the year ending March 31, 2025

• Forecast for the year ending March 31, 2025: Summary

• Forecast for the year ending March 31, 2025: Financial Highlights

• Shareholder Returns Policy in the period of the Medium-Term Management Plan

• Revision of business segment (From FY2025/3)

• Forecast for the year ending March 31, 2025: Forecast by Segment (New Segment)

• Forecast for the year ending March 31, 2025: Imaging Products Business

• Forecast for the year ending March 31, 2025: Precision Equipment Business

• Forecast for the year ending March 31, 2025: Healthcare Business

• Forecast for the year ending March 31, 2025: Components Business

• Forecast for the year ending March 31, 2025: Digital Manufacturing Business

• Forecast for the year ending March 31, 2025: Summary(Reposted)

• Shareholder Returns Policy in the period of the Medium-Term Management Plan(Reposted)

Progress Report on Medium-Term Management Plan (FY 2022 -2025)

• Overview of progress in the Medium-Term Management Plan

• Revenue and capital allocation

• Latest outlook to earnings by business

• Mid/long-term revenue portfolio

• Initiatives aimed at earnings expansion: QOL

• Initiatives aimed at earnings expansion: Industry

• Strengthen business fundamentals

• Overview of the Medium-term Management Plan

• Vision 2030

@